Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome
This study has suspended participant recruitment.
( pending further evaluation )
Study NCT01325740   Information provided by Seaside Therapeutics, Inc.

First Received on March 28, 2011.   Last Updated on December 19, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fragile X Syndrome
More general conditions related to this trial
Chromosome Disorders
Congenital Abnormalities
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Heredodegenerative Disorders, Nervous System
Mental Retardation
Mental Retardation, X-Linked
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Sex Chromosome Disorders
Interventions listed in this trial
STX107
Sponsors listed in this trial
Seaside Therapeutics, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services